Unstable angina non ST elevation myocardial infarction: Difference between revisions

Acute Coronary Syndrome Main Page
	Unstable angina / NSTEMI Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Unstable Angina
Non-ST Elevation Myocardial Infarction
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders
Epidemiology and Demographics
Risk Stratification
Natural History, Complications and Prognosis
Special Groups
Women
Heart Failure and Cardiogenic Shock
Perioperative NSTE-ACS Related to Noncardiac Surgery
Stress (Takotsubo) Cardiomyopathy
Diabetes Mellitus
Post CABG Patients
Older Adults
Chronic Kidney Disease
Angiographically Normal Coronary Arteries
Variant (Prinzmetal's) Angina
Substance Abuse
Cardiovascular "Syndrome X"
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Blood Studies
Biomarkers
Electrocardiogram
Chest X Ray
Echocardiography
Coronary Angiography
Treatment
Primary Prevention
Immediate Management
Anti-Ischemic and Analgesic Therapy
Cholesterol Management
Antitplatelet Therapy
Antiplatelet therapy recommendations
Aspirin
Thienopyridines
Glycoprotein IIb/IIIa Inhibitor
Anticoagulant Therapy
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS
Mechanical Reperfusion
Initial Conservative Versus Initial Invasive Strategies
PCI
CABG
Complications of Bleeding and Transfusion
Discharge Care
Medical Regimen
Post-Discharge Follow-Up
Cardiac Rehabilitation
Long-Term Medical Therapy and Secondary Prevention
ICD implantation within 40 days of myocardial infarction
ICD within 90 days of revascularization
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Unstable angina non ST elevation myocardial infarction On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Unstable angina non ST elevation myocardial infarction
CDC onUnstable angina non ST elevation myocardial infarction
Unstable angina non ST elevation myocardial infarction in the news
Blogs on Unstable angina non ST elevation myocardial infarction
to Hospitals Treating Unstable angina non ST elevation myocardial infarction
Risk calculators and risk factors for Unstable angina non ST elevation myocardial infarction

VisualWikitext

Latest revision as of 20:57, 5 December 2022

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.; Neil Gheewala, M.D. [3]; Bryan Piccirillo, B.S., M.D.

Synonyms and keywords: Angina at rest; rest angina; progressive angina; crescendo angina; accelerating angina; new-onset angina; pre-infarction angina; unstable angina pectoris; UAP; UA; new-onset angina; angina - unstable

Overview

Classification

Pathophysiology

Unstable Angina | Non-ST Elevation Myocardial Infarction

Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders

Epidemiology and Demographics

Risk Stratification

Natural History, Complications and Prognosis

Special Groups

Diagnosis

Treatment

Primary Prevention

Antiplatelet Agents: Antiplatelet Therapy Recommendations | Aspirin | Thienopyridines | Glycoprotein IIb/IIIa Inhibitor | Additional Management Considerations

Mechanical Reperfusion: Initial Conservative Versus Initial Invasive Strategies | PCI | CABG

Discharge Care: Medical Regimen | Post-Discharge Follow-Up | Cardiac Rehabilitation

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Contraindicated medications

Unstable angina is considered an absolute contraindication to the use of the following medications:

Case Studies

Case #1

Related Chapters

External Links

Clinical Trial Results: An up to date resource of Cardiovascular Research
Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack - based on information of the Framingham Heart Study, from the United States National Heart, Lung and Blood Institute

Template:WikiDoc Sources

@@ Line 2: / Line 2: @@
 {| class="infobox" style="float:right;"
 |-
-| [[File:Siren.gif|30px|link=Acute coronary syndrome intern survival guide]]|| <br> || <br>
+| [[File:Siren.gif|30px|link=Unstable angina/ NSTEMI resident survival guide]]|| <br> || <br>
-| [[Acute coronary syndrome intern survival guide|Intern <br> Survival   <br> Guide]]
+| [[Unstable angina/ NSTEMI resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
 |}
 {{Unstable angina / NSTEMI}}
@@ Line 17: / Line 17: @@
 ==[[Unstable angina / non ST elevation myocardial infarction classification | Classification]]==
-==Pathophysiology==
+==[[Unstable angina / non ST elevation myocardial infarction pathophysiology| Pathophysiology]]==
 [[Unstable angina pathophysiology|Unstable Angina]] | [[Non ST elevation myocardial infarction pathophysiology|Non-ST Elevation Myocardial Infarction]]
@@ Line 55: / Line 55: @@
 '''[[Unstable angina / non ST elevation myocardial infarction future or investigational therapies|Future or Investigational Therapies]]'''
+====Contraindicated medications====
+{{MedCondContrAbs|MedCond = Unstable angina|Dalteparin|Fingolimod|Levothyroxine}}
 ==Case Studies==
@@ Line 60: / Line 63: @@
 ==Related Chapters==
-* [[The Living Guidelines: UA/NSTEMI | The UA / NSTEMI Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]]
+* [[Acute Coronary Syndrome risk stratification|Acute Coronary Syndrome Risk Stratification]]
 * [[Chronic stable angina]]
 * [[Non ST Elevation Myocardial Infarction]]
@@ Line 66: / Line 69: @@
 * [[Coronary Heart Disease]]
 * [[PCI]]
-*[[News:Unstable Angina (UA) and Non-ST-Elevation Myocardial Infarction (NSTEMI) ACC/AHA Guidelines Updated]]
-*[[Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment]]
-*[[The Living Guidelines: Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI View the Current CLASS I Guidelines|Current CLASS I Living Guidelines:Initial Conservative versus Initial Invasive Strategies in patients with UA/NSTEMI]]
-*[[The Living Guidelines: Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI View the Current CLASS IIa Guidelines|Current CLASS IIa Living Guidelines:Initial Conservative versus Initial Invasive Strategies in patients with UA/NSTEMI]]
-*[[The Living Guidelines: Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI Polling Results for CLASS IIb Guidelines|Current CLASS IIb Living Guidelines:Initial Conservative versus Initial Invasive Strategies in patients with UA/NSTEMI]]
-*[[The Living Guidelines: Initial Conservative versus Initial Invasive Strategies in patients with Unstable Angina / Non ST Elevation MI Polling Results for CLASS III Guidelines|Current CLASS III Living Guidelines:Initial Conservative versus Initial Invasive Strategies in patients with UA/NSTEMI]]
 ==External Links==
@@ Line 79: / Line 76: @@
 {{WikiDoc Sources}}
-[[Category:Best pages]]
 [[Category:Ischemic heart diseases]]
 [[Category:Intensive care medicine]]
@@ Line 88: / Line 84: @@
 [[Category:Up-To-Date]]
 [[Category:Up-To-Date cardiology]]
-[[Category:Primary care]]
+[[Category:Best pages]]